Novartis AG Cash Flows From Used In Investing Activities Continuing Operations
Novartis AG (NVS) reported Cash Flows From Used In Investing Activities Continuing Operations of -$4.88 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations · last filed 2026-02-04
- Novartis AG cash flows from used in investing activities continuing operations for the quarter ending 2024-06-30 was -$3.21B.
- Novartis AG cash flows from used in investing activities continuing operations for the quarter ending 2023-06-30 was -$960.00M.
- Novartis AG cash flows from used in investing activities continuing operations for the quarter ending 2022-06-30 was -$11.63B, a 11965.31% decline year-over-year.
- Novartis AG cash flows from used in investing activities continuing operations for the quarter ending 2021-06-30 was $98.00M.
| Period end | Cash Flows From Used In Investing Activities Continuing Operations 3 month | Cash Flows From Used In Investing Activities Continuing Operations 3 month as first filed | Cash Flows From Used In Investing Activities Continuing Operations 6 month | Cash Flows From Used In Investing Activities Continuing Operations 6 month as first filed | Cash Flows From Used In Investing Activities Continuing Operations 12 month | Cash Flows From Used In Investing Activities Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$4.88B 20-F · filed 2026-02-04 | |||||
| 2024-12-31 | -$7.51B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | -$3.21B 6-K · filed 2024-07-18 | -$4.11B 6-K · filed 2024-07-18 | ||||
| 2023-12-31 | $6.72B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | -$960.00M 6-K · filed 2024-07-18 | $9.74B 6-K · filed 2024-07-18 | ||||
| 2022-12-31 | $1.90B 20-F · filed 2025-01-31 | $1.47B 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | -$11.63B 6-K · filed 2022-07-19 | -$2.26B 6-K · filed 2022-07-19 | ||||
| 2021-12-31 | $4.90B 20-F · filed 2024-01-31 | $4.21B 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $98.00M 6-K · filed 2022-07-19 | $883.00M 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | -$13.05B 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | -$334.00M 6-K · filed 2021-07-21 | -$10.46B 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | -$1.07B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $208.00M 6-K · filed 2020-07-21 | $1.96B 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | -$4.59B 20-F · filed 2021-01-26 | -$5.59B 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | $4.46B 6-K · filed 2019-07-18 | $4.33B 6-K · filed 2018-07-18 | $503.00M 6-K · filed 2019-07-18 | $230.00M 6-K · filed 2018-07-18 | ||
| 2017-12-31 | -$2.34B 20-F · filed 2020-01-29 | -$2.98B 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | -$297.00M 6-K · filed 2018-07-18 | -$1.35B 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | -$2.69B 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | -$19.67B 6-K · filed 2018-01-24 |